Results 141 to 150 of about 120,934 (309)

Reevaluating the rule of two's: Age and epidemiological variations in Meckel's diverticulum

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objective To evaluate the clinical characteristics, diagnostic modalities, and age‐related variation of Meckel's diverticulum (MD) using data from a nationwide pediatric inpatient database and a single‐center institutional cohort. Methods The Kids' Inpatient Database (KID) for 2016 and 2019 was queried for patients with a principal diagnosis ...
Ashley Polachek   +5 more
wiley   +1 more source

Yield of adenomas and colorectal cancers within 5 years of a negative colonoscopy: are the guidelines guiding?

open access: yes, 2016
Background: Screening for colorectal cancers outside the recommended guidelines presents a considerable burden to resource management in many public hospitals.
Stephensen, B   +7 more
core   +1 more source

The safe and effective use of tofacitinib and ustekinumab combination therapy in infantile onset inflammatory bowel disease

open access: yesJPGN Reports, EarlyView.
Abstract Infantile‐onset inflammatory bowel disease (IOIBD) is a rare and severe subset of very‐early‐onset IBD, often associated with immune dysregulation and poor response to conventional therapies. Data regarding the use of Janus kinase inhibitors (JAKI) in this population is limited.
Smridhi Mahajan   +2 more
wiley   +1 more source

Assessing pediatric gastroenterologists' use of artificial intelligence in clinical and professional tasks

open access: yesJPGN Reports, EarlyView.
Abstract Objectives Artificial intelligence (AI) has demonstrated potential to enhance clinical efficiency. However, its real‐world adoption among pediatric gastroenterologists (GIs) remains poorly characterized. The primary objective of this study was to assess how pediatric GIs are currently utilizing AI. Secondary objectives included estimating time
Ashwin Agrawal   +3 more
wiley   +1 more source

Influencing factors of colonoscopy screening in first-degree relatives of hospitalized colorectal cancer patients and preliminary clinical practices to improve the compliance

open access: yesFrontiers in Oncology
ObjectivesThis study aimed to analyze the factors that influence colonoscopy screening in first-degree relatives (FDRs) of patients with colorectal cancer (CRC) and explore the feasibility to invite FDRs to undergo a colonoscopy to improve screening ...
Dongqin Zhao   +4 more
doaj   +1 more source

Sedation for Colonoscopy Procedures Using Dexmedetomidine Versus Propofol-Fentanyl Infusions: A Prospective Randomized Controlled Trial

open access: yes
Objective: Different anaesthetists for sedation or monitored anaesthesia care have been used for colonoscopy. The target of this research was the ability to perform colonoscopy under a painless degree of sedation and the prevalence of undesired ...
Mohamed Abdelgawad Abdelhalim Aboelsuod   +3 more
core   +1 more source

Pediatric Clostridiodes difficile infection with toxic megacolon successfully treated with fecal microbiota transplantation

open access: yesJPGN Reports, EarlyView.
Abstract The rising incidence of pediatric Clostridioides difficile infection (CDI), particularly in medically complex patients, calls for novel, individualized treatments. While fecal microbiota transplantation (FMT) is well‐described for recurrent CDI, this report describes the first pediatric case of fulminant CDI with toxic megacolon successfully ...
Dana McCarney   +3 more
wiley   +1 more source

Colonoscopy images

open access: yes, 2019
Original frame image was extracted from colonoscopy video. In this study, colonoscopy was performed using a high-resolution colonoscopy device (CV260SL, Olympus, Tokyo, Japan).
Minwoo Cho (6517757)
core   +1 more source

Outcomes of adalimumab biosimilar nonmedical switches in children and young adults with inflammatory bowel disease

open access: yesJPGN Reports, EarlyView.
Abstract Objectives Adalimumab biosimilars are as safe and effective compared to the originator. Adult patients with inflammatory bowel disease (IBD) who switched to a biosimilar have comparable outcomes, but pediatric data are limited. This study evaluates clinical outcomes of children and young adults with IBD following a nonmedical, insurance‐driven
Daniel Himelstein   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy